References
Nakajima Y, Tachimori H, Miyawaki Y, et al. A survey of the clinical outcomes of cervical esophageal carcinoma surgery focusing on the presence or absence of laryngectomy using the National Clinical Database in Japan. Esophagus. 2022;19:569–75.
Shah MA, Kennedy EB, Catenacci DV, et al. Treatment of locally advanced esophageal carcinoma: ASCO guideline. J Clin Oncol. 2020;38:2677–94.
Kato K, Ito Y, Daiko H, et al. A randomized controlled Phase III trial comparing doublet chemotherapy, triplet chemotherapy, and doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced esophageal cancer: the JCOG1109 NExT study. Lancet. (in press).
Kubo Y, Makino T, Yamasaki M, et al. Three-course neoadjuvant chemotherapy associated with unfavorable survival of non-responders to the first two courses for locally advanced esophageal cancer. Ann Surg Oncol. 2023;30:5899–907.
Kubo Y, Nozaki R, Igaue S, et al. Neoadjuvant chemotherapy improves feasibility of larynx preservation and prognosis for resectable locally advanced cervical esophageal cancer. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15432-4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Ken Kato reports funding from Merck Sharp & Dohme Corp. (MSD), Ono Pharmaceuticals, Bristol Myers Squibb (BMS), Beigene, Shionogi, Merck Biopharma, Oncolys BioPharma, Daiichi Sankyo, Novartis, Taiho Pharmaceutical, Janssen, AstraZeneca, and Chugai, paid to his institution. Yuto Kubo and Hiroyuki Daiko have no disclosures to declare in relation to this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article refers to: Kubo Y, Nozaki R, Igaue S, et al. Neoadjuvant chemotherapy improves feasibility of larynx preservation and prognosis for resectable locally advanced cervical esophageal cancer. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15432-4.
Rights and permissions
About this article
Cite this article
Kubo, Y., Kato, K. & Daiko, H. ASO Author Reflections: Neoadjuvant Chemotherapy versus Definitive Chemoradiation Therapy for Locally Advanced Cervical Esophageal Cancer: A Retrospective Study. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15520-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1245/s10434-024-15520-5